help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

Published ahead of print on May 4, 2006, doi:10.1165/rcmb.2006-0128OC

Am. J. Respir. Cell Mol. Biol., Volume 35, Number 4, October 2006, 474-478

A more recent version of this article appeared on October 1, 2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0128OCv1
35/4/474    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arredouani, M. S
Right arrow Articles by Kobzik, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arredouani, M. S
Right arrow Articles by Kobzik, L.

Submitted on March 29, 2006
Revised on May 4, 2006

The Macrophage Scavenger Receptor SR-AI/II and Lung Defense against Pneumococci and Particles

Mohamed S Arredouani1, Zhiping Yang1, Amy Imrich1, YaoYu Ning1, Guozhong Qin1, and Lester Kobzik2*

1 Physiology Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA, 2 Physiology Program, Department of Environmental Health, Harvard School of Public Health, Boston, MA, USA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA

* To whom correspondence should be addressed. E-mail: lkobzik{at}hsph.harvard.edu.

The class A macrophage scavenger receptor SR-AI/II is implicated as a pattern recognition receptor for innate immunity, but its functional role in lung defense has not been studied. We used mice genetically deficient in SR-AI/II and their wild-type C57BL/6 counterparts to investigate the contribution of this receptor to defense against pneumococcal infection and inhaled particles. SR-AI/II deficiency caused impaired phagocytosis of fluorescent bacteria in vivo, diminished clearance of live bacteria from the lungs, and substantially increased pneumonic inflammation. Survival studies also showed increased mortality in SR-AI/II-deficient mice with pneumococcal lung infection. Similarly, after challenge of the airways with TiO2 particles, SR-AI/II-deficient mice showed increased proinflammatory cytokine levels in lung lavage fluid and a more pronounced neutrophilic inflammation. The data indicate that the lung macrophage class A scavenger receptor SRAI/II contributes to innate defense against bacteria and inhaled particles.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2006 American Thoracic Society.
  ATS Best of the Web